Sep 28, 2026 07:01AM
Sep 23, 2026 08:25AM
Jul 31, 2026 08:10AM
Jul 6, 2026 08:33AM
May 21, 2026 05:02PM
May 13, 2026 08:03AM
May 12, 2026 09:30AM Moleculin's Annamycin shows no significant heart toxicity in leukemia study
May 8, 2026 08:45AM
Apr 23, 2026 08:27AM
Mar 27, 2026 04:03PM
Mar 23, 2026 08:33AM
Feb 19, 2026 08:39AM
Feb 18, 2026 08:20AM
Feb 13, 2026 08:35AM Moleculin launches CEO Corner platform for investor communication
Jan 13, 2026 08:55AM
Jan 12, 2026 08:37AM
Dec 23, 2025 04:49PM
Dec 10, 2025 08:30AM
Dec 8, 2025 08:21AM
Oct 29, 2025 08:35AM
Sep 10, 2025 07:33AM H.C. Wainwright Reiterates Buy Rating on Moleculin Biotech (MBRX)
Aug 13, 2025 07:11PM
Aug 6, 2025 08:42AM
Jul 30, 2025 08:35AM
Jul 22, 2025 08:40AM
Jul 9, 2025 08:37AM
Jun 20, 2025 09:20AM
Jun 18, 2025 07:30AM Moleculin Biotech (MBRX) Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML
Jun 9, 2025 06:14AM
Jun 4, 2025 08:46AM
May 14, 2025 04:30PM
May 12, 2025 08:40AM
May 5, 2025 08:45AM
Apr 29, 2025 08:36AM
Mar 25, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Moleculin Biotech (MBRX)
Mar 6, 2025 08:32AM
Mar 3, 2025 06:41AM
Feb 25, 2025 12:35PM
Feb 13, 2025 01:07PM
Feb 13, 2025 09:25AM
Feb 11, 2025 08:40AM
Nov 14, 2024 08:16AM Moleculin Biotech (MBRX) Accelerates Planned Unblinded Data Readout for MIRACLE Phase 3 R/R Acute Myeloid Leukemia Trial
Nov 12, 2024 08:03AM
Aug 16, 2024 08:00AM
Aug 14, 2024 01:25PM
Aug 1, 2024 08:32AM
Jul 10, 2024 08:30AM
Jun 14, 2024 08:00AM

471,231 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All